Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04025047

A Multi-center Registry Study: The Follow-up the Complications for Trans-vaginal Mesh Surgery

A Multi-center Registry Study: The Complications After Women Having Pelvic Reconstruction Surgery With Trans-vaginal Mesh

Status
Recruiting
Phase
Study type
Observational
Enrollment
4,147 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multi-center, prospective, observational, hospital-based registry of pelvic organ prolapse(POP) patients who having trans-vaginal mesh implantation with 12 month and 36 month follow-up.To investigate the incidence of postoperative complications according to the International Urogynecological Association/International Continence Society (IUGA/ICS) complication classification system(the Category- Time-Site(CTS) coding).

Detailed description

Patients who undergo pelvic floor reconstructive surgery with trans-vaginal mesh for the cure of pelvic organ prolapse (POP) between June 2019 and December 2022 from 41 centers across the country are going to be prospectively collected. The study is designed to report the clinical data,outcomes and complications of transvaginal mesh surgery in China. The information gathered will identify the incidence rate of complications, especially mesh exposure/erosion, in Chinese women and whether published, professional guidelines on POP surgical treatment as well as mesh complications management are being applied appropriately. Findings from this registry may help in knowing the current status of transvaginal mesh use in China as well as identify issues that may affect the surgical outcome and complications occurrence. Based on the registry study, clinical practice on the management of transvaginal mesh implantation including selection patients, pre- and post-operative evaluation and complications surgical database will be established. The follow-up process starts after patients have completed the operation; thus, our study does not affect patients' choice of surgical method.

Conditions

Timeline

Start date
2019-04-10
Primary completion
2025-12-01
Completion
2026-06-01
First posted
2019-07-18
Last updated
2019-07-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04025047. Inclusion in this directory is not an endorsement.